Agriculture & Agritech Global On demand · 24-48h

Global Poultry Probiotic Ingredients Market Strategic Research Report

Global Poultry Probiotic Ingredients Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Poultry Probiotic Ingredients Market
$1162025
6.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Bacillus-Based Preparations, Lactic-Acid-Bacteria Preparations, Clostridium And Live Yeast Preparations, Others

By Application: Broilers, Layers, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novonesis A/S, Evonik Industries AG, Adisseo France S.A.S., Kemin Industries, Inc., dsm-firmenich AG, Lallemand Inc., Huvepharma EOOD, Lesaffre, Asahi Biocycle Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., International Animal Health Products Pty Ltd., Unique Biotech Limited, Beijing Scitop Bio-Tech Co., Ltd., Qingdao Vland Biotech Inc., Shandong Baolai-Leelai Bioengineering Co., Ltd., Xinjiang Xipu Biotechnology Co., Ltd., Guangdong Hinabiotech Co., Ltd., Shanxi Dayu Bioengineering Co., Ltd., Angel Yeast Co., Ltd., Shandong Sukahan Bio-Technology Co., Ltd., Wuhan Heyuan Green Biological Co., Ltd., Hubei Langu Zhongwei Biotechnology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 162 pages
Market size 2025
$116
Million USD
Forecast CAGR
6.2%
2025-2032
Forecast 2032
$176.7
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Poultry Probiotic Ingredients market size is predicted to grow from US$ 116 million in 2025 to US$ 176 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Poultry Probiotic Ingredients are functional feed-additive ingredients containing identified, safety-assessed, and efficacy-selected viable bacteria, yeasts, or microbial consortia. They are manufactured through fermentation, concentration, drying, stabilization, encapsulation, and carrier standardization for administration through poultry feed, drinking water, or hatchery systems. Major microorganisms include Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus coagulans, Clostridium butyricum, Lactobacillus, Pediococcus, Enterococcus, and Saccharomyces cerevisiae.

These ingredients support poultry performance by regulating intestinal microbiota, competitively excluding undesirable microorganisms, producing organic acids and antimicrobial metabolites, improving nutrient digestion, maintaining intestinal-barrier integrity, and supporting immune responses. They are used to improve feed-conversion efficiency, weight gain, flock uniformity, survival, laying persistence, and egg quality. Complete feeds, non-viable prebiotics, standalone enzymes, acidifiers, phytogenic products, antibiotics, vaccines, and inactivated postbiotics are excluded.

In 2025, global shipments of Poultry Probiotic Ingredients are estimated at 12,500 tons, with a price of approximately US$9,000 per ton and a gross profit margin of approximately 38%-42%.

Growth in global poultry-meat and egg consumption, expansion of integrated poultry production, and efforts to reduce antibiotic growth promoters are shifting probiotics from supplementary additives toward routine gut-health management tools. Broiler producers increasingly focus on feed-conversion ratio, daily weight gain, survival, and processing uniformity, while layer and breeder operations prioritize laying persistence, eggshell quality, reproductive performance, and stress recovery. Increasing industrialization of poultry production in Asia, Latin America, the Middle East, and Africa is creating additional demand for heat-stable spore products, multi-strain formulations, and water-administered probiotics.

Competition is shifting from total viable counts stated on product labels toward strain-specific performance, commercial-farm validation, post-pelleting survival, and guaranteed viable counts at the end of shelf life. Sporulation, high-density fermentation, freeze-drying, microencapsulation, and protective carriers improve resistance to pelleting heat, gastric acid, bile salts, transportation, and storage conditions. Product delivery is also expanding from conventional in-feed use toward drinking-water administration, hatchery spray, gel delivery, and whole-cycle programs tailored to bird age, diet, and pathogen pressure.

Key market risks include inconsistent results across diets and farming environments, microbial losses during feed pelleting, competition from low-priced products with inadequate viable counts, and lengthy strain-level safety and efficacy registration. Avian-disease outbreaks, feed-industry margin pressure, and poultry-production cycles can also affect procurement. Large poultry integrators and feed manufacturers will increasingly require strain traceability, antimicrobial-resistance screening, end-of-shelf-life guarantees, compatibility with coccidiostats and organic acids, and measurable improvements in feed conversion and mortality under commercial conditions. Suppliers with proprietary strain libraries, industrial fermentation, formulation technology, and field-service capabilities will be better positioned to gain market share.

This report presents a comprehensive overview of the global Poultry Probiotic Ingredients market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Bacillus-Based Preparations
  • Lactic-Acid-Bacteria Preparations
  • Clostridium And Live Yeast Preparations
  • Others

Segment by Strain Composition

  • Single-Strain Preparation
  • Multi-Strain Preparation
  • Synbiotic Or Microbial Compound
  • Others

Segment by Form

  • Dry Feed-Grade Powder And Granule
  • Water-Soluble Powder And Tablet
  • Liquid Suspension And Concentrate
  • Others

Segment by Application

  • Broilers
  • Layers
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Poultry Probiotic Ingredients market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Broilers, Layers, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Poultry Probiotic Ingredients Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$116
2025
Forecast
$176.7
2032
CAGR
6.2%
2025–2032
区域
5
global
Key companies
Novonesis A/SEvonik Industries AGAdisseo France S.A.S.Kemin Industries, Inc.dsm-firmenich AGLallemand Inc.Huvepharma EOODLesaffre
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Bacillus-Based PreparationsLactic-Acid-Bacteria PreparationsClostridium And Live Yeast PreparationsOthers
By Application
BroilersLayersOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Bacillus-Based Preparations
  • 3.1.3 Lactic-Acid-Bacteria Preparations
  • 3.1.4 Clostridium And Live Yeast Preparations
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Broilers
  • 4.1.3 Layers
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novonesis A/S
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Evonik Industries AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Adisseo France S.A.S.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Kemin Industries, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 dsm-firmenich AG
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Lallemand Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Huvepharma EOOD
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Lesaffre
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Asahi Biocycle Co., Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Miyarisan Pharmaceutical Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 International Animal Health Products Pty Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Unique Biotech Limited
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Beijing Scitop Bio-Tech Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Qingdao Vland Biotech Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Baolai-Leelai Bioengineering Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Xinjiang Xipu Biotechnology Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Guangdong Hinabiotech Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shanxi Dayu Bioengineering Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Angel Yeast Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shandong Sukahan Bio-Technology Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Wuhan Heyuan Green Biological Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Hubei Langu Zhongwei Biotechnology Co., Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Poultry Probiotic Ingredients market?
The global Poultry Probiotic Ingredients market is estimated at US$ 116 million in 2025 (base year) and is projected to reach US$ 176 million by 2032.
How fast is the Poultry Probiotic Ingredients market expected to grow?
The market is expected to grow at a CAGR of 6.2% from 2026 to 2032, expanding from US$ 116 million in 2025 to US$ 176 million in 2032, roughly 1.5 times its base-year value.
What does the Poultry Probiotic Ingredients market cover?
Poultry Probiotic Ingredients are functional feed-additive ingredients containing identified, safety-assessed, and efficacy-selected viable bacteria, yeasts, or microbial consortia. They are manufactured through fermentation, concentration, drying, stabilization, encapsulation, and carrier standardization for administration through poultry feed, drinking water, or hatchery systems.
What are the main segments of the Poultry Probiotic Ingredients market by type?
By type, the market is segmented into Bacillus-Based Preparations, Lactic-Acid-Bacteria Preparations, Clostridium And Live Yeast Preparations and Others.
Which applications drive demand in the Poultry Probiotic Ingredients market?
Key applications covered include Broilers, Layers and Others.
Who are the key players in the Poultry Probiotic Ingredients market?
Key players profiled include Novonesis A/S, Evonik Industries AG, Adisseo France S.A.S., Kemin Industries, dsm-firmenich AG, Lallemand Inc., Huvepharma EOOD and Lesaffre, among 22 companies covered in total.
Which regions and countries are covered for Poultry Probiotic Ingredients?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What challenges does the Poultry Probiotic Ingredients market face?
These ingredients support poultry performance by regulating intestinal microbiota, competitively excluding undesirable microorganisms, producing organic acids and antimicrobial metabolites, improving nutrient digestion, maintaining intestinal-barrier integrity, and supporting immune responses.
Who should buy the Poultry Probiotic Ingredients market report?
The report is intended for manufacturers and solution providers, distributors and end users in Broilers, Layers and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Poultry Probiotic Ingredients market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.